|
Volumn 3, Issue 4, 2003, Pages 263-264
|
Vaginal microbicides: A priority need for women's health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIVIRUS AGENT;
BACTERICIDE;
CARRAGEENAN;
CELLABURATE;
CELLULOSE SULFATE;
DEODORANT AGENT;
DEXTRIN;
MONOCLONAL ANTIBODY;
NAPHTHALENESULFONIC ACID DERIVATIVE;
NONOXINOL 9;
POLYPEPTIDE ANTIBIOTIC AGENT;
POLYSACCHARIDE SULFATE;
TOPICAL ANTIINFECTIVE AGENT;
AFRICA SOUTH OF THE SAHARA;
CONDOM;
DISEASE TRANSMISSION;
DRUG DESIGN;
ECTOPIC PREGNANCY;
HEALTH CARE FINANCING;
HUMAN;
INCIDENCE;
INFECTION PREVENTION;
INFECTION RISK;
INFECTION SENSITIVITY;
INFERTILITY;
NOTE;
PUBLIC HEALTH SERVICE;
SEXUAL BEHAVIOR;
SEXUALLY TRANSMITTED DISEASE;
UTERINE CERVIX CARCINOMA;
ARTICLE;
COST OF ILLNESS;
DRUG INDUSTRY;
ECONOMICS;
FEMALE;
HEALTH CARE PLANNING;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVAGINAL DRUG ADMINISTRATION;
WOMEN'S HEALTH;
ADMINISTRATION, INTRAVAGINAL;
ANTI-INFECTIVE AGENTS, LOCAL;
COST OF ILLNESS;
DISEASE TRANSMISSION, HORIZONTAL;
DRUG INDUSTRY;
FEMALE;
HEALTH PRIORITIES;
HIV INFECTIONS;
HUMANS;
SEXUALLY TRANSMITTED DISEASES;
WOMEN'S HEALTH;
|
EID: 0141497982
PISSN: 15345874
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (7)
|
References (0)
|